{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:15:17Z","timestamp":1787318117858,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2023YFC2508106"],"award-info":[{"award-number":["2023YFC2508106"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073429"],"award-info":[{"award-number":["82073429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273510"],"award-info":[{"award-number":["82273510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103714"],"award-info":[{"award-number":["82103714"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation Program of Shanghai Municipal Education Commission","award":["No.2019-01-07-00-07-E00046"],"award-info":[{"award-number":["No.2019-01-07-00-07-E00046"]}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["No.2020CR1014B"],"award-info":[{"award-number":["No.2020CR1014B"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["22022302"],"award-info":[{"award-number":["22022302"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal hospital diagnosis and treatment technology promotion and optimization management project","award":["SHDC12023114"],"award-info":[{"award-number":["SHDC12023114"]}]},{"name":"Project of Shanghai Municipal Health Commission","award":["202240369"],"award-info":[{"award-number":["202240369"]}]},{"name":"Central university basic scientific research business fund project plan","award":["22120240331"],"award-info":[{"award-number":["22120240331"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40257-025-00918-y","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:03:59Z","timestamp":1737543839000},"page":"291-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Impact of Family History on Clinical Presentation and Biologic Treatment Response in Patients with Psoriasis: A Multicenter Prospective Cohort Study"],"prefix":"10.1007","volume":"26","clinical-trial-number":[{"clinical-trial-number":"chictr2000036186","registry":"10.18810\/chictr"}],"author":[{"given":"Yuxiong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1273-7881","authenticated-orcid":false,"given":"Yuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"918_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397:1301\u201315.","journal-title":"Lancet"},{"key":"918_CR2","doi-asserted-by":"publisher","first-page":"102916","DOI":"10.1016\/j.jaut.2022.102916","volume":"133","author":"J Yu","year":"2022","unstructured":"Yu J, Zhao Q, Wang X, Zhou H, Hu J, Gu L, Hu Y, Zeng F, Zhao F, Yue C, et al. Pathogenesis, multi-omics research, and clinical treatment of psoriasis. J Autoimmun. 2022;133:102916.","journal-title":"J Autoimmun"},{"key":"918_CR3","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1136\/annrheumdis-2012-201308","volume":"71","author":"L Eder","year":"2012","unstructured":"Eder L, Chandran V, Pellett F, Shanmugarajah S, Rosen CF, Bull SB, Gladman DD. Differential human leucocyte allele association between psoriasis and psoriatic arthritis: a family-based association study. Ann Rheum Dis. 2012;71:1361\u20135.","journal-title":"Ann Rheum Dis"},{"key":"918_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/1346-8138.13157","volume":"43","author":"J Luis Lopez-Estebaranz","year":"2016","unstructured":"Luis Lopez-Estebaranz J, Luis Sanchez-Carazo J, Sulleiro S. Effect of a family history of psoriasis and age on comorbidities and quality of life in patients with moderate to severe psoriasis: results from the ARIZONA study. J Dermatol. 2016;43:395\u2013401.","journal-title":"J Dermatol"},{"key":"918_CR5","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.jaad.2020.06.081","volume":"83","author":"J Ya","year":"2020","unstructured":"Ya J, Hu JZ, Nowacki AS, Khanna U, Mazloom S, Kabbur G, Husni ME, Fernandez AP. Family history of psoriasis, psychological stressors, and tobacco use are associated with the development of tumor necrosis factor-\u03b1 inhibitor-induced psoriasis: a case-control study. J Am Acad Dermatol. 2020;83:1599\u2013605.","journal-title":"J Am Acad Dermatol"},{"key":"918_CR6","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1136\/annrheumdis-2015-207670","volume":"75","author":"T Frisell","year":"2016","unstructured":"Frisell T, Saevarsdottir S, Askling J. Does a family history of RA influence the clinical presentation and treatment response in RA? Ann Rheum Dis. 2016;75:1120\u20135.","journal-title":"Ann Rheum Dis"},{"key":"918_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/03009742.2021.1887928","volume":"51","author":"M Morin","year":"2022","unstructured":"Morin M, Hellgren K, Lindstrom U, Frisell T. Is family history a predictor of response to tumour necrosis factor inhibitors in spondyloarthritis? A Swedish nationwide cohort study. Scand J Rheumatol. 2022;51:10\u201320.","journal-title":"Scand J Rheumatol"},{"key":"918_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00296-019-04464-9","volume":"40","author":"K Murata","year":"2020","unstructured":"Murata K, Hashimoto M, Yamamoto W, Son Y, Amuro H, Nagai K, Takeuchi T, Katayama M, Maeda Y, Ebina K, et al. The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study. Rheumatol Int. 2020;40:217\u201325.","journal-title":"Rheumatol Int"},{"key":"918_CR9","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis a review. JAMA. 2020;323:1945\u201360.","journal-title":"JAMA"},{"key":"918_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/17512433.2020.1767590","volume":"13","author":"Y-C Tsai","year":"2020","unstructured":"Tsai Y-C, Tsai T-F. Switching biologics in psoriasis-practical guidance and evidence to support. Expert Rev Clin Pharmacol. 2020;13:493\u2013503.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"918_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/bjd\/ljae147","volume":"191","author":"D Huang","year":"2024","unstructured":"Huang D, Zhong X, Jiang Y, Kong L, Ma R, Lu J, Li Y, Shi Y. Insulin resistance impairs biologic agent response in moderate-to-severe plaque psoriasis: insights from a prospective cohort study in China. Br J Dermatol. 2024;191:616\u201323.","journal-title":"Br J Dermatol"},{"key":"918_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/bjd\/ljad188","volume":"189","author":"N Yu","year":"2023","unstructured":"Yu N, Peng C, Zhou J, Gu J, Xu J, Li X, Bi X, Deng H, Li X, Ding Y, Shi Y. Measurement properties of the patient global assessment numerical rating scale in moderate-to-severe psoriasis. Br J Dermatol. 2023;189:437\u201346.","journal-title":"Br J Dermatol"},{"key":"918_CR13","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/1346-8138.16733","volume":"50","author":"C Ohata","year":"2023","unstructured":"Ohata C, Anezaki H, Kaneko S, Okazaki F, Ito K, Matsuzaka Y, Kikuchi S, Koike Y, Murota H, Miyagi T, et al. Clinical characteristics of patients with psoriasis with family history: a multicenter observational study. J Dermatol. 2023;50:746\u201352.","journal-title":"J Dermatol"},{"key":"918_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1067\/mjd.2002.120470","volume":"46","author":"C Ferr\u00e1ndiz","year":"2002","unstructured":"Ferr\u00e1ndiz C, Pujol RM, Garc\u00eda-Patos V, Bordas X, Smand\u00eda JA. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol. 2002;46:867\u201373.","journal-title":"J Am Acad Dermatol"},{"key":"918_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/bjd.12371","volume":"169","author":"C Remrod","year":"2013","unstructured":"Remrod C, Sjostrom K, Svensson A. Psychological differences between early- and late-onset psoriasis: a study of personality traits, anxiety and depression in psoriasis. Br J Dermatol. 2013;169:344\u201350.","journal-title":"Br J Dermatol"},{"key":"918_CR16","doi-asserted-by":"publisher","first-page":"E454","DOI":"10.1111\/jdv.17944","volume":"36","author":"F Manzo Margiotta","year":"2022","unstructured":"Manzo Margiotta F, Michelucci A, Panduri S, Tonini A, Davini G, Romanelli M, Morganti R, Dini V. Family history of psoriasis: a novel protective factor for therapy switch in patients treated with secukinumab or ixekizumab. J Euro Acad Dermatol Venereol. 2022;36:E454\u20136.","journal-title":"J Euro Acad Dermatol Venereol"},{"key":"918_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s40257-022-00722-y","volume":"23","author":"T Torres","year":"2022","unstructured":"Torres T, Puig L, Vender R, Yeung J, Carrascosa J-M, Piaserico S, Gisondi P, Lynde C, Ferreira P, Bastos PM, et al. Drug survival of interleukin (IL)-17 and IL-23 inhibitors for the treatment of psoriasis: a retrospective multi-country, multicentric cohort study. Am J Clin Dermatol. 2022;23:891\u2013904.","journal-title":"Am J Clin Dermatol"},{"key":"918_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jaad.2019.01.035","volume":"88","author":"H-Y Chiu","year":"2023","unstructured":"Chiu H-Y, Hui RC-Y, Tsai T-F, Chen Y-C, Liao N-FC, Chen P-H, Lai P-J, Wang T-S, Huang Y-H. Predictors of time to relapse following ustekinumab withdrawal in patients with psoriasis who had responded to therapy: an 8-year multicenter study. J Am Acad Dermatol. 2023;88:71\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"918_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1046\/j.1365-2133.2003.05115.x","volume":"148","author":"JE Gudjonsson","year":"2003","unstructured":"Gudjonsson JE, Karason A, Antonsdottir A, Runarsdottir EH, Hauksson VB, Upmanyu R, Gulcher J, Stefansson K, Valdimarsson H. Patients with psoriasis who are homozygous for the HLA-Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes. Br J Dermatol. 2003;148:233\u20135.","journal-title":"Br J Dermatol"},{"key":"918_CR20","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.jaci.2018.11.038","volume":"143","author":"N Dand","year":"2019","unstructured":"Dand N, Duckworth M, Baudry D, Russell A, Curtis CJ, Lee SH, Evans I, Mason KJ, Alsharqi A, Becher G, et al. HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis. J Allergy Clin Immunol. 2019;143:2120\u201330.","journal-title":"J Allergy Clin Immunol"},{"key":"918_CR21","doi-asserted-by":"publisher","first-page":"E611","DOI":"10.1111\/jdv.18870","volume":"37","author":"M Siewertsen","year":"2023","unstructured":"Siewertsen M, Al-Sofi R, Dridi H, Ajenthen GDD, Zachariae C, Skov L, Loft N. Association between HLA-Cw6 and response to treatment with biologics in patients with psoriasis: a systematic review and meta-analysis. J Euro Acad Dermatol Venereol. 2023;37:E611\u20134.","journal-title":"J Euro Acad Dermatol Venereol"},{"key":"918_CR22","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1001\/jamadermatol.2019.0098","volume":"155","author":"LJ van Vugt","year":"2019","unstructured":"van Vugt LJ, van den Reek JMPA, Hannink G, Coenen MJH, de Jong EMGJ. Association of HLA-C*06:02 status with differential response to ustekinumab in patients with psoriasis: a systematic review and meta-analysis. JAMA Dermatol. 2019;155:708\u201315.","journal-title":"JAMA Dermatol"},{"key":"918_CR23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0190-9622(85)70188-0","volume":"13","author":"T Henseler","year":"1985","unstructured":"Henseler T, Christophers E. Psoriasis of early and late onset\u2014characterization of 2 types of psoriasis-vulgaris. J Am Acad Dermatol. 1985;13:450\u20136.","journal-title":"J Am Acad Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00918-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-025-00918-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00918-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T03:26:40Z","timestamp":1740367600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-025-00918-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["918"],"URL":"https:\/\/doi.org\/10.1007\/s40257-025-00918-y","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"7 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was sponsored by grants from the National Key Research and Development Program of China (2023YFC2508106), National Natural Science Foundation of China (no. 82073429, 82273510, 82103714), Innovation Program of Shanghai Municipal Education Commission (no. 2019-01-07-00-07-E00046), Clinical Research Plan of SHDC (no. 2020CR1014B, 22022302), Shanghai Municipal Hospital Diagnosis and Treatment Technology Promotion and Optimization Management Project (SHDC12023114), Project of Shanghai Municipal Health Commission (202240369), and Central University Basic Scientific Research Business Fund Project Plan (22120240331).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The data that support the findings of this study are available from the corresponding author upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"This study was approved by the Medical Ethical Committee of Shanghai Skin Disease Hospital (approval no. 2020-36), the Ethics Committee of Shanghai Changhai Hospital (approval no. 2020-27), the Ethics Committee of Shanghai Sixth People\u2019s Hospital (approval no. 2020-KY-047K) and the Ethics Committee of Shanghai Tenth People\u2019s Hospital (approval no. 20KT110).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"All participants provided written informed consent prior to any study-related procedures.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Patients signed informed consent regarding the publishing of vtheir data.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Y.J.: writing\u2014original draft, conceptualization, investigation, and visualization; X.L.: writing\u2014original draft; R.M.: writing\u2014investigation and visualization; L.Y.: writing\u2014original draft and investigation; D.H.: writing\u2014original draft; X.Z.: writing\u2014original draft and visualization; Y.W.: writing\u2014original draft; S.X.: conceptualization and methodology; Y. L.: writing\u2014original draft and conceptualization; X.Z.: writing\u2014review and editing, resources, and methodology; J.L.: writing\u2014review and editing, resources, methodology, and funding acquisition; and Y.S.: writing\u2014review and editing, conceptualization, and funding acquisition. All authors gave final approval of the version to be published.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}